The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoFlu Hospitalization Rate Week 16, 2026?
Flu Hospitalization Rate Week 16, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$10,331 Wol.
$10,331 Wol.
May 1, 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$10,331 Wol.
$10,331 Wol.
May 1, 2026
<80
$728 Wol.
No
80–85
$2,893 Wol.
No
85–90
$3,655 Wol.
Yes
90–95
$1,610 Wol.
No
95–100
$805 Wol.
No
100+
$640 Wol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Rynek otwarty: Apr 24, 2026, 11:18 AM ET
Wolumen
$10,331Data zakończenia
May 1, 2026Rynek otwarty
Apr 24, 2026, 11:18 AM ETResolver
0x69c47De9D...Wynik zaproponowany: No
Brak sporu
Ostateczny wynik: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Wolumen
$10,331Data zakończenia
May 1, 2026Rynek otwarty
Apr 24, 2026, 11:18 AM ETResolver
0x69c47De9D...Wynik zaproponowany: No
Brak sporu
Ostateczny wynik: No
The CDC FluSurv-NET surveillance system's latest preliminary data through Week 15 (ending April 18, 2026) reports a cumulative influenza-associated hospitalization rate of 85.2 per 100,000 population—the third highest since the 2010-2011 season—driving trader consensus to 100% implied probability for the 85–90 range in Week 16. This reflects the 2025-26 flu season's severity, with a peak weekly rate of 13.5 per 100,000 in early February amid widespread influenza A(H1N1)pdm09 and A(H3N2) activity, now tapering to minimal levels (Week 16 weekly rate estimated at 0.6 per 100,000). Final FluView confirmation expected soon could revise rates slightly due to reporting lags, though significant shifts are unlikely given stabilizing trends in prior weeks.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania